Action Cortex Pharm - COR

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Cortex Receives Delisting Notification from NYSE Amex

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) announced that it has received notification from the NYSE Amex LLC indicating that...

Cortex Reports Third Quarter Operating Results

Cortex Pharmaceuticals, Inc. (NYSE Amex (COR)) reported a net loss applicable to common stock of $3,243,000, or $0.06 per share...

Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) President and CEO, Mark A. Varney, Ph.D., will present at Rodman & Renshaw’s...

Cortex Receives NYSE Amex Staff Determination

Cortex Pharmaceuticals, Inc. (NYSE Amex (COR)) reported that it has received a delisting notification from the NYSE Amex LLC...

Cortex Reports Second Quarter Operating Results

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) reported a net loss applicable to common stock of $2,778,000, or $0.06 per share...

Cortex Pharmaceuticals Announces Financing

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) reported that it has entered into a definitive agreement with a single...

Cortex Annual Shareholder Meeting Notification

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR), a neuroscience company focused on developing novel AMPAKINE? drug therapies for...

Cortex Receives Notice of Non-Compliance from NYSE Amex for Continued Listing Requirements

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) reported that it has received notice from the NYSE Amex LLC indicating that the...

Cortex Reports First Quarter Operating Results

Cortex Pharmaceuticals, Inc. (NYSE Amex: COR) reported a net loss of $3,168,000, or $0.07 per share for the quarter ended March...

Cortex Announces Closing of Financing

Cortex Pharmaceuticals, Inc. (NYSE Amex:COR) announced that it has completed the previously announced sale of shares of a...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

COR - Frequently Asked Questions (FAQ)

What is the current Cortex Pharm share price?

The current share price of Cortex Pharm is US$ 0,00

What is the 1 year trading range for Cortex Pharm share price?

Cortex Pharm has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 7,05 (24,12%)	106,27M
MSOXAdvisorShares MSOS Daily Leveraged ETF	US$ 5,54 (19,91%)	546,85k
NAKNorthern Dynasty Minerals Ltd	US$ 0,7297 (16,16%)	12,19M
BGIBirks Group Inc	US$ 1,16 (16,00%)	240,69k
YINNDirexion Daily FTSE China Bull 3X Shares	US$ 46,09 (14,77%)	10,52M
EXODExodus Movement Inc	US$ 29,00 (-31,73%)	186,17k
SGNSigning Day Sports Inc	US$ 0,81 (-25,00%)	691,99k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 16,1801 (-24,60%)	33,98M
IBOImpact Biomedical Inc	US$ 1,1801 (-18,05%)	28,18k
YANGDirexion Daily FTSE China Bear 3X Shares New	US$ 37,30 (-14,65%)	8,38M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 21,95 (6,30%)	117,7M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6,45 (-3,15%)	112,8M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 7,05 (24,12%)	106,27M
FXIiShares China Large Cap	US$ 36,79 (4,99%)	84,64M
XLFFinancial Select Sector	US$ 50,21 (0,58%)	74,93M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cortex Pharmaceuticals, (COR)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

COR Dernières nouvelles

Cortex Receives Delisting Notification from NYSE Amex

Cortex Reports Third Quarter Operating Results

Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009

Cortex Receives NYSE Amex Staff Determination

Cortex Reports Second Quarter Operating Results

Cortex Pharmaceuticals Announces Financing

Cortex Annual Shareholder Meeting Notification

Cortex Receives Notice of Non-Compliance from NYSE Amex for Continued Listing Requirements

Cortex Reports First Quarter Operating Results

Cortex Announces Closing of Financing

COR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cortex Pharmaceuticals, (COR) Cours

Cortex Pharmaceuticals, (COR)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

COR Dernières nouvelles

Cortex Receives Delisting Notification from NYSE Amex

Cortex Reports Third Quarter Operating Results

Cortex’s CEO to Present at Rodman & Renshaw’s Eleventh Annual Healthcare Conference on September 10, 2009

Cortex Receives NYSE Amex Staff Determination

Cortex Reports Second Quarter Operating Results

Cortex Pharmaceuticals Announces Financing

Cortex Annual Shareholder Meeting Notification

Cortex Receives Notice of Non-Compliance from NYSE Amex for Continued Listing Requirements

Cortex Reports First Quarter Operating Results

Cortex Announces Closing of Financing

COR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE